Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome
Open Access
- 19 January 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (9) , 15071-15084
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Thomas R. Reich1, Olivier J. Switzeny1, Mirjam Renovanz2, Clemens Sommer3, Bernd Kaina1, Markus Christmann1, Maja T. Tomicic1 1Department of Toxicology, University Medical Center, D-55131 Mainz, Germany 2Department of Neurosurgery, University Medical Center, D-55131 Mainz, Germany 3Department of Neuropathology, University Medical Center, D-55131 Mainz, Germany Correspondence to: Maja T. Tomicic, email: tomicic@uni-mainz.de Markus Christmann, email: mchristm@uni-mainz.de Keywords: high-grade glioma, glioblastoma, temozolomide, XAF1 promoter methylation, IDH1 Received: July 22, 2016 Accepted: January 10, 2017 Published: January 19, 2017Keywords
This publication has 57 references indexed in Scilit:
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- Identification of additional IDH mutations associated with oncometabolite R(−)-2-hydroxyglutarate productionOncogene, 2011
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiformeCell Death & Disease, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- The p53 family and programmed cell deathOncogene, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005